Clinical Trial Update: Temozolomide in Treating Patients With Brain Metastases [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated temozolomide for patients with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain Tumors
• Central Nervous System Tumors

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED